Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nanoparticles | 49 | 2023 | 1962 | 7.230 |
Why?
|
RNA, Small Interfering | 19 | 2023 | 3419 | 2.610 |
Why?
|
Nanomedicine | 11 | 2022 | 286 | 1.950 |
Why?
|
Drug Delivery Systems | 18 | 2023 | 2207 | 1.930 |
Why?
|
Nanotechnology | 12 | 2023 | 703 | 1.760 |
Why?
|
Polymers | 15 | 2023 | 1621 | 1.550 |
Why?
|
Drug Carriers | 7 | 2021 | 700 | 1.180 |
Why?
|
Melanins | 2 | 2021 | 291 | 1.110 |
Why?
|
RNA, Messenger | 8 | 2023 | 12769 | 1.100 |
Why?
|
Gene Transfer Techniques | 6 | 2017 | 1216 | 1.020 |
Why?
|
Lipids | 5 | 2021 | 3315 | 0.980 |
Why?
|
RNA | 4 | 2023 | 2717 | 0.920 |
Why?
|
Cancer Vaccines | 3 | 2020 | 1044 | 0.900 |
Why?
|
PTEN Phosphohydrolase | 2 | 2021 | 1118 | 0.900 |
Why?
|
Polyethylene Glycols | 10 | 2021 | 1188 | 0.880 |
Why?
|
Antioxidants | 3 | 2021 | 1670 | 0.840 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2023 | 2941 | 0.790 |
Why?
|
Neoplasms | 18 | 2021 | 22345 | 0.760 |
Why?
|
Tumor Microenvironment | 5 | 2022 | 3948 | 0.720 |
Why?
|
Nucleic Acids | 1 | 2023 | 193 | 0.710 |
Why?
|
Dendrimers | 1 | 2020 | 72 | 0.660 |
Why?
|
Liver Failure, Acute | 1 | 2021 | 183 | 0.650 |
Why?
|
Mice, Nude | 9 | 2019 | 3614 | 0.610 |
Why?
|
Plaque, Atherosclerotic | 6 | 2024 | 1530 | 0.600 |
Why?
|
Cell Line, Tumor | 19 | 2023 | 17062 | 0.590 |
Why?
|
Hydrogels | 1 | 2023 | 728 | 0.560 |
Why?
|
HeLa Cells | 9 | 2017 | 3067 | 0.550 |
Why?
|
Photochemotherapy | 1 | 2023 | 825 | 0.530 |
Why?
|
RNA Interference | 5 | 2021 | 2828 | 0.520 |
Why?
|
Phospholipids | 3 | 2008 | 776 | 0.490 |
Why?
|
Nanostructures | 5 | 2020 | 548 | 0.490 |
Why?
|
Atherosclerosis | 9 | 2024 | 3425 | 0.430 |
Why?
|
Robotics | 1 | 2020 | 808 | 0.430 |
Why?
|
Metal Nanoparticles | 1 | 2018 | 403 | 0.430 |
Why?
|
Lipid Bilayers | 3 | 2008 | 376 | 0.380 |
Why?
|
Reactive Oxygen Species | 5 | 2023 | 2141 | 0.370 |
Why?
|
Small Molecule Libraries | 1 | 2017 | 741 | 0.370 |
Why?
|
Repressor Proteins | 3 | 2020 | 2968 | 0.370 |
Why?
|
Hydrogen-Ion Concentration | 5 | 2019 | 2477 | 0.360 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2019 | 2056 | 0.350 |
Why?
|
Serum Albumin, Bovine | 2 | 2008 | 319 | 0.350 |
Why?
|
G(M1) Ganglioside | 2 | 2008 | 87 | 0.350 |
Why?
|
Animals | 42 | 2025 | 168731 | 0.340 |
Why?
|
Microscopy, Electron, Transmission | 3 | 2021 | 685 | 0.330 |
Why?
|
Blood Platelets | 1 | 2020 | 2463 | 0.330 |
Why?
|
Mice | 27 | 2025 | 81792 | 0.320 |
Why?
|
Macrophages | 8 | 2024 | 5772 | 0.320 |
Why?
|
Biocompatible Materials | 3 | 2019 | 1683 | 0.320 |
Why?
|
Prostatic Neoplasms | 4 | 2021 | 11080 | 0.320 |
Why?
|
Pharmaceutical Preparations | 4 | 2023 | 1084 | 0.320 |
Why?
|
Phagocytosis | 3 | 2024 | 1518 | 0.310 |
Why?
|
Molecular Imprinting | 1 | 2008 | 12 | 0.310 |
Why?
|
Apoptosis | 8 | 2024 | 9511 | 0.310 |
Why?
|
Cholera Toxin | 2 | 2008 | 563 | 0.290 |
Why?
|
Immunotherapy | 3 | 2022 | 4752 | 0.290 |
Why?
|
Biological Products | 1 | 2017 | 942 | 0.290 |
Why?
|
Particle Size | 4 | 2017 | 1631 | 0.280 |
Why?
|
Tissue Distribution | 4 | 2021 | 2266 | 0.280 |
Why?
|
Endothelial Cells | 3 | 2025 | 3584 | 0.270 |
Why?
|
Prodrugs | 2 | 2019 | 273 | 0.260 |
Why?
|
Mice, Inbred C57BL | 11 | 2025 | 22321 | 0.260 |
Why?
|
Gene Silencing | 4 | 2017 | 1505 | 0.260 |
Why?
|
Hydrogen Peroxide | 2 | 2021 | 743 | 0.260 |
Why?
|
Membrane Lipids | 1 | 2007 | 240 | 0.250 |
Why?
|
Tissue Engineering | 2 | 2019 | 1855 | 0.250 |
Why?
|
Surface Properties | 5 | 2021 | 1152 | 0.250 |
Why?
|
Genetic Vectors | 1 | 2015 | 3404 | 0.250 |
Why?
|
Nanocapsules | 2 | 2020 | 92 | 0.250 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13448 | 0.240 |
Why?
|
Neoplasms, Experimental | 3 | 2020 | 1229 | 0.230 |
Why?
|
Protein Interaction Mapping | 1 | 2008 | 619 | 0.230 |
Why?
|
Collagen Type IV | 2 | 2021 | 124 | 0.220 |
Why?
|
Levodopa | 2 | 2021 | 221 | 0.220 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2024 | 120 | 0.220 |
Why?
|
Brain Ischemia | 1 | 2017 | 3000 | 0.210 |
Why?
|
Mice, Inbred BALB C | 4 | 2021 | 6219 | 0.210 |
Why?
|
Anti-Inflammatory Agents | 3 | 2021 | 1807 | 0.210 |
Why?
|
Proteins | 4 | 2023 | 5996 | 0.210 |
Why?
|
Antineoplastic Agents | 6 | 2020 | 13639 | 0.210 |
Why?
|
Thyroid Neoplasms | 1 | 2016 | 2350 | 0.200 |
Why?
|
Melanoma | 1 | 2021 | 5690 | 0.200 |
Why?
|
Humans | 53 | 2025 | 765734 | 0.200 |
Why?
|
Tryptophan | 1 | 2024 | 483 | 0.200 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2024 | 222 | 0.200 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2025 | 548 | 0.190 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2008 | 788 | 0.190 |
Why?
|
Delayed-Action Preparations | 2 | 2016 | 967 | 0.190 |
Why?
|
Indocyanine Green | 1 | 2023 | 233 | 0.180 |
Why?
|
Putrescine | 1 | 2021 | 42 | 0.180 |
Why?
|
Ornithine Decarboxylase | 1 | 2021 | 63 | 0.180 |
Why?
|
Urease | 1 | 2020 | 43 | 0.180 |
Why?
|
Genes, abl | 1 | 2020 | 69 | 0.180 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2022 | 4642 | 0.170 |
Why?
|
Enzymes, Immobilized | 1 | 2020 | 53 | 0.170 |
Why?
|
Oxidative Stress | 3 | 2021 | 3140 | 0.170 |
Why?
|
Dendritic Cells | 3 | 2020 | 2746 | 0.170 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2019 | 3605 | 0.160 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2020 | 179 | 0.160 |
Why?
|
Hydrodynamics | 1 | 2020 | 163 | 0.160 |
Why?
|
Transfection | 2 | 2018 | 5744 | 0.160 |
Why?
|
Benzylamines | 2 | 2017 | 251 | 0.160 |
Why?
|
Phosphorus | 2 | 2017 | 337 | 0.150 |
Why?
|
Photosensitizing Agents | 1 | 2023 | 625 | 0.150 |
Why?
|
Ovalbumin | 1 | 2020 | 674 | 0.150 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2025 | 1118 | 0.150 |
Why?
|
Silicon Dioxide | 1 | 2019 | 217 | 0.150 |
Why?
|
Benzoates | 2 | 2017 | 213 | 0.150 |
Why?
|
Infrared Rays | 2 | 2017 | 246 | 0.150 |
Why?
|
Autophagy | 2 | 2024 | 1352 | 0.150 |
Why?
|
Disease Models, Animal | 7 | 2021 | 18289 | 0.150 |
Why?
|
Membrane Potentials | 1 | 2021 | 1083 | 0.150 |
Why?
|
Hydroxyl Radical | 1 | 2018 | 82 | 0.150 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2018 | 81 | 0.150 |
Why?
|
Phototherapy | 2 | 2019 | 369 | 0.150 |
Why?
|
Cisplatin | 3 | 2019 | 1657 | 0.140 |
Why?
|
Osmotic Pressure | 1 | 2018 | 136 | 0.140 |
Why?
|
Receptors, CXCR4 | 1 | 2022 | 728 | 0.140 |
Why?
|
Methacrylates | 1 | 2017 | 109 | 0.140 |
Why?
|
Polysaccharides, Bacterial | 1 | 2020 | 576 | 0.140 |
Why?
|
Genes, Tumor Suppressor | 1 | 2021 | 1059 | 0.140 |
Why?
|
Molecular Structure | 2 | 2020 | 1885 | 0.130 |
Why?
|
Bone Regeneration | 1 | 2019 | 436 | 0.130 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5388 | 0.130 |
Why?
|
Motion | 1 | 2020 | 781 | 0.130 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 2017 | 90 | 0.130 |
Why?
|
Antibodies | 2 | 2019 | 2416 | 0.130 |
Why?
|
Peptides | 2 | 2019 | 4331 | 0.130 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2016 | 62 | 0.130 |
Why?
|
Ferric Compounds | 1 | 2018 | 368 | 0.130 |
Why?
|
Tissue Scaffolds | 2 | 2019 | 934 | 0.130 |
Why?
|
Quantum Dots | 1 | 2017 | 169 | 0.130 |
Why?
|
Ligands | 2 | 2017 | 3273 | 0.130 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2020 | 689 | 0.120 |
Why?
|
Fluorescent Antibody Technique | 1 | 2019 | 2470 | 0.120 |
Why?
|
Protein Engineering | 1 | 2019 | 550 | 0.120 |
Why?
|
Glutarates | 1 | 2017 | 243 | 0.120 |
Why?
|
Azepines | 1 | 2017 | 327 | 0.120 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2019 | 679 | 0.120 |
Why?
|
Boronic Acids | 2 | 2021 | 916 | 0.120 |
Why?
|
Fibronectins | 1 | 2018 | 720 | 0.120 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2020 | 5336 | 0.120 |
Why?
|
Endosomes | 1 | 2018 | 522 | 0.120 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1994 | 0.120 |
Why?
|
Endocytosis | 1 | 2019 | 951 | 0.120 |
Why?
|
Receptors, LDL | 1 | 2017 | 491 | 0.120 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2025 | 2896 | 0.110 |
Why?
|
Pharmacokinetics | 1 | 2014 | 86 | 0.110 |
Why?
|
Molecular Targeted Therapy | 2 | 2018 | 2822 | 0.110 |
Why?
|
Interleukin-10 | 2 | 2021 | 1183 | 0.110 |
Why?
|
Wound Healing | 1 | 2025 | 2790 | 0.110 |
Why?
|
Chlamydia trachomatis | 1 | 2015 | 240 | 0.110 |
Why?
|
Protein Binding | 5 | 2021 | 9299 | 0.110 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 3 | 2021 | 391 | 0.100 |
Why?
|
Reference Standards | 1 | 2017 | 1013 | 0.100 |
Why?
|
Gold | 2 | 2017 | 482 | 0.100 |
Why?
|
Cells | 1 | 2014 | 162 | 0.100 |
Why?
|
Bacterial Vaccines | 1 | 2015 | 399 | 0.100 |
Why?
|
Polyglycolic Acid | 1 | 2014 | 406 | 0.100 |
Why?
|
Oxygen | 2 | 2021 | 4242 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3805 | 0.100 |
Why?
|
Antigens, Surface | 1 | 2017 | 1617 | 0.100 |
Why?
|
Male | 14 | 2025 | 363585 | 0.100 |
Why?
|
Inflammation | 4 | 2024 | 10846 | 0.100 |
Why?
|
Muscle Proteins | 1 | 2018 | 1160 | 0.100 |
Why?
|
Doxorubicin | 1 | 2019 | 2229 | 0.100 |
Why?
|
Equipment Design | 1 | 2020 | 3485 | 0.100 |
Why?
|
Adjuvants, Immunologic | 2 | 2015 | 995 | 0.100 |
Why?
|
Chlamydia Infections | 1 | 2015 | 364 | 0.100 |
Why?
|
Molecular Imaging | 1 | 2018 | 822 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3673 | 0.090 |
Why?
|
Collagen | 1 | 2019 | 2618 | 0.090 |
Why?
|
Uterus | 1 | 2015 | 661 | 0.090 |
Why?
|
Vaccines, Synthetic | 1 | 2014 | 621 | 0.090 |
Why?
|
Enzyme Inhibitors | 1 | 2021 | 3717 | 0.090 |
Why?
|
Mice, SCID | 1 | 2016 | 2627 | 0.090 |
Why?
|
Biological Transport | 1 | 2015 | 2080 | 0.090 |
Why?
|
Disulfides | 3 | 2018 | 462 | 0.090 |
Why?
|
Aptamers, Nucleotide | 1 | 2012 | 163 | 0.090 |
Why?
|
Cysteine | 1 | 2015 | 898 | 0.090 |
Why?
|
Signal Transduction | 3 | 2025 | 23589 | 0.090 |
Why?
|
Mice, Knockout | 3 | 2021 | 14445 | 0.090 |
Why?
|
Th1 Cells | 1 | 2015 | 1039 | 0.090 |
Why?
|
Vaccination | 2 | 2020 | 3427 | 0.080 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2012 | 296 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2454 | 0.080 |
Why?
|
Transplantation, Heterologous | 1 | 2018 | 2393 | 0.080 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 6109 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2022 | 2328 | 0.080 |
Why?
|
Iron | 1 | 2018 | 1814 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2018 | 2878 | 0.080 |
Why?
|
Lactic Acid | 1 | 2014 | 1138 | 0.080 |
Why?
|
Hyperthermia, Induced | 1 | 2012 | 414 | 0.080 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1892 | 0.080 |
Why?
|
Pyrazines | 1 | 2014 | 1204 | 0.080 |
Why?
|
Borates | 1 | 2008 | 17 | 0.080 |
Why?
|
Immunologic Memory | 1 | 2015 | 1375 | 0.080 |
Why?
|
Cell Proliferation | 3 | 2021 | 10428 | 0.070 |
Why?
|
Silicates | 1 | 2008 | 49 | 0.070 |
Why?
|
Liver | 2 | 2021 | 7559 | 0.070 |
Why?
|
Oxidation-Reduction | 3 | 2020 | 2218 | 0.070 |
Why?
|
Haptens | 1 | 2008 | 163 | 0.070 |
Why?
|
Contrast Media | 1 | 2021 | 5326 | 0.070 |
Why?
|
Antigen-Antibody Reactions | 1 | 2008 | 340 | 0.070 |
Why?
|
Glass | 1 | 2008 | 116 | 0.070 |
Why?
|
Microscopy, Atomic Force | 1 | 2008 | 250 | 0.070 |
Why?
|
Cells, Cultured | 5 | 2021 | 18972 | 0.070 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2051 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2022 | 4352 | 0.060 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 3431 | 0.060 |
Why?
|
Glutathione | 2 | 2018 | 589 | 0.060 |
Why?
|
Models, Chemical | 1 | 2008 | 608 | 0.060 |
Why?
|
Epithelial Cells | 1 | 2017 | 3683 | 0.060 |
Why?
|
DNA | 2 | 2020 | 7200 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5693 | 0.060 |
Why?
|
Kynurenine | 1 | 2024 | 142 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2021 | 65180 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6307 | 0.050 |
Why?
|
Transforming Growth Factors | 1 | 2023 | 76 | 0.050 |
Why?
|
Rabbits | 2 | 2019 | 4733 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5781 | 0.050 |
Why?
|
Cattle | 1 | 2008 | 3800 | 0.050 |
Why?
|
Antigen Presentation | 1 | 2008 | 1250 | 0.050 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2023 | 192 | 0.050 |
Why?
|
Microfluidics | 1 | 2007 | 651 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2014 | 2564 | 0.050 |
Why?
|
Hypoglycemic Agents | 1 | 2014 | 3109 | 0.050 |
Why?
|
Ubiquitins | 1 | 2023 | 365 | 0.050 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2010 | 2203 | 0.050 |
Why?
|
Cholesterol | 2 | 2022 | 2898 | 0.050 |
Why?
|
Basement Membrane | 1 | 2021 | 348 | 0.040 |
Why?
|
Microscopy, Fluorescence | 1 | 2008 | 2626 | 0.040 |
Why?
|
Drug Compounding | 1 | 2021 | 235 | 0.040 |
Why?
|
Rats | 1 | 2017 | 23704 | 0.040 |
Why?
|
Cytoplasm | 2 | 2018 | 1497 | 0.040 |
Why?
|
Anti-Retroviral Agents | 1 | 2010 | 1786 | 0.040 |
Why?
|
Female | 8 | 2022 | 395961 | 0.040 |
Why?
|
Insulin | 1 | 2014 | 6601 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2017 | 6356 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2025 | 1151 | 0.040 |
Why?
|
Aptamers, Peptide | 1 | 2018 | 29 | 0.040 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2024 | 751 | 0.040 |
Why?
|
Porosity | 1 | 2019 | 347 | 0.040 |
Why?
|
Immunoglobulins | 1 | 2002 | 852 | 0.040 |
Why?
|
Biomimetics | 1 | 2019 | 167 | 0.040 |
Why?
|
Biomimetic Materials | 1 | 2019 | 170 | 0.040 |
Why?
|
Drug Resistance, Multiple | 1 | 2019 | 255 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 798 | 0.040 |
Why?
|
Transcription Factors | 1 | 2017 | 12123 | 0.040 |
Why?
|
Neovascularization, Physiologic | 1 | 2025 | 1377 | 0.040 |
Why?
|
Molybdenum | 1 | 2017 | 45 | 0.040 |
Why?
|
Coated Materials, Biocompatible | 1 | 2019 | 314 | 0.040 |
Why?
|
Free Radical Scavengers | 1 | 2018 | 213 | 0.040 |
Why?
|
Joints | 1 | 2019 | 321 | 0.040 |
Why?
|
Cell Survival | 2 | 2019 | 5747 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2023 | 1458 | 0.030 |
Why?
|
Graphite | 1 | 2017 | 79 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2023 | 871 | 0.030 |
Why?
|
Finite Element Analysis | 1 | 2019 | 441 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2019 | 720 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5195 | 0.030 |
Why?
|
Th17 Cells | 1 | 2022 | 786 | 0.030 |
Why?
|
Amides | 1 | 2018 | 455 | 0.030 |
Why?
|
Anisotropy | 1 | 2019 | 1284 | 0.030 |
Why?
|
Spectrum Analysis | 1 | 2017 | 443 | 0.030 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2016 | 201 | 0.030 |
Why?
|
Cartilage | 1 | 2019 | 797 | 0.030 |
Why?
|
Caco-2 Cells | 1 | 2016 | 365 | 0.030 |
Why?
|
Skull | 1 | 2019 | 814 | 0.030 |
Why?
|
Integrin alpha Chains | 1 | 2015 | 93 | 0.030 |
Why?
|
Vaccines, Inactivated | 1 | 2015 | 185 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2002 | 2194 | 0.030 |
Why?
|
Immunoconjugates | 1 | 2002 | 979 | 0.030 |
Why?
|
Cytokines | 2 | 2022 | 7424 | 0.030 |
Why?
|
Orphan Nuclear Receptors | 1 | 2014 | 63 | 0.030 |
Why?
|
Chondrocytes | 1 | 2019 | 799 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2021 | 1489 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2018 | 36537 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2022 | 11641 | 0.030 |
Why?
|
Intracellular Space | 1 | 2014 | 198 | 0.030 |
Why?
|
Toll-Like Receptor 8 | 1 | 2014 | 98 | 0.030 |
Why?
|
KB Cells | 1 | 2012 | 12 | 0.030 |
Why?
|
Alendronate | 1 | 2014 | 174 | 0.030 |
Why?
|
Toll-Like Receptor 9 | 1 | 2014 | 197 | 0.030 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2015 | 416 | 0.030 |
Why?
|
Toll-Like Receptor 7 | 1 | 2014 | 169 | 0.030 |
Why?
|
Osteogenesis | 1 | 2019 | 1282 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2014 | 705 | 0.030 |
Why?
|
Platinum | 1 | 2013 | 219 | 0.020 |
Why?
|
Luciferases | 1 | 2013 | 713 | 0.020 |
Why?
|
Taxoids | 1 | 2015 | 665 | 0.020 |
Why?
|
Mucous Membrane | 1 | 2015 | 656 | 0.020 |
Why?
|
Peritonitis | 1 | 2014 | 368 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2019 | 21053 | 0.020 |
Why?
|
Skin | 1 | 2025 | 4474 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2008 | 7849 | 0.020 |
Why?
|
Oligopeptides | 1 | 2016 | 1192 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2011 | 0.020 |
Why?
|
Histones | 1 | 2021 | 2592 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2015 | 1099 | 0.020 |
Why?
|
Regeneration | 1 | 2019 | 1517 | 0.020 |
Why?
|
Triglycerides | 1 | 2017 | 2441 | 0.020 |
Why?
|
Antibody Formation | 1 | 2014 | 1391 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 3110 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1663 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2020 | 3451 | 0.020 |
Why?
|
Antigens | 1 | 2014 | 1438 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2014 | 1554 | 0.020 |
Why?
|
Imidazoles | 1 | 2014 | 1163 | 0.020 |
Why?
|
Temperature | 1 | 2014 | 2226 | 0.020 |
Why?
|
Spleen | 1 | 2014 | 2295 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4405 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2015 | 1811 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4255 | 0.020 |
Why?
|
Phenotype | 1 | 2024 | 16706 | 0.020 |
Why?
|
Antigens, CD | 1 | 2015 | 4020 | 0.010 |
Why?
|
Models, Biological | 1 | 2021 | 9441 | 0.010 |
Why?
|
Biomedical Research | 1 | 2019 | 3458 | 0.010 |
Why?
|
HIV Infections | 1 | 2010 | 17531 | 0.010 |
Why?
|
Communicable Disease Control | 1 | 2010 | 856 | 0.010 |
Why?
|
Gold Colloid | 1 | 2002 | 12 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7584 | 0.010 |
Why?
|
Carcinoma | 1 | 2012 | 2309 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 11888 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15542 | 0.010 |
Why?
|
Binding Sites | 1 | 2008 | 6001 | 0.010 |
Why?
|
Immunoassay | 1 | 2002 | 742 | 0.010 |
Why?
|
Computer Simulation | 1 | 2008 | 6252 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 59459 | 0.010 |
Why?
|
Aged | 1 | 2018 | 171050 | 0.000 |
Why?
|
Middle Aged | 1 | 2018 | 222903 | 0.000 |
Why?
|
Adult | 1 | 2018 | 222974 | 0.000 |
Why?
|